Rep. Cleo Fields Buys Quantinuum Inc. (NASDAQ:QNT) Shares

Representative Cleo Fields (Democratic-Louisiana) recently bought shares of Quantinuum Inc. (NASDAQ:QNT). In a filing disclosed on June 26th, the Representative disclosed that they had bought between $1,001 and $15,000 in Quantinuum stock on June 4th. The trade occurred in the Representative’s “MORGAN STANLEY – E*TRADE #2” account.

Representative Cleo Fields also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 6/15/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/11/2026.
• Purchased $1,001 – $15,000 in shares of Apple (NASDAQ:AAPL) on 5/14/2026.
• Purchased $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 4/9/2026.

Quantinuum Stock Performance

NASDAQ:QNT opened at $72.84 on Tuesday. Quantinuum Inc. has a 12-month low of $50.10 and a 12-month high of $81.48.

Quantinuum News Roundup

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Multiple firms initiated coverage on Quantinuum with bullish calls, including JPMorgan, Rosenblatt, Craig Hallum, Bank of America, Needham, Mizuho, and Sanford C. Bernstein, with several price targets implying meaningful upside. Analyst coverage and price targets
• Positive Sentiment: Rosenblatt was the most bullish, assigning a buy rating and a $155 target, signaling strong confidence in Quantinuum’s long-term growth potential. Rosenblatt coverage
• Positive Sentiment: Congressional trading activity also drew attention after Rep. Cleo Fields reportedly made a new quantum-related bet, adding to investor interest in the sector. Congressman Who Buys Magnificent Seven Stocks With Size Made New Quantum Bet
• Neutral Sentiment: Morgan Stanley initiated coverage with an equal weight rating and a $78 target, which is more cautious than peers but still above the recent trading level. Morgan Stanley coverage
• Negative Sentiment: Despite the bullish analyst wave, the stock has been falling, suggesting investors may be taking profits or reacting to valuation concerns after the sharp run-up in interest around quantum computing. Quantinuum stock falls: why is Wall Street bullish on the stock?

Analyst Ratings Changes

A number of research firms recently weighed in on QNT. Bank of America started coverage on Quantinuum in a report on Monday. They set a “buy” rating and a $100.00 target price on the stock. Craig Hallum assumed coverage on Quantinuum in a report on Monday. They set a “buy” rating and a $100.00 price target for the company. Morgan Stanley started coverage on shares of Quantinuum in a report on Monday. They issued an “equal weight” rating and a $78.00 price objective on the stock. Jefferies Financial Group assumed coverage on shares of Quantinuum in a research report on Monday. They issued a “buy” rating and a $90.00 price objective on the stock. Finally, UBS Group started coverage on shares of Quantinuum in a report on Monday. They set a “buy” rating and a $93.00 target price for the company. Twelve equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

Insider Transactions at Quantinuum

In other Quantinuum news, insider Kevin Scott Dehoff bought 15,000 shares of Quantinuum stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $900,000.00. Following the completion of the transaction, the insider owned 126,460 shares in the company, valued at $7,587,600. The trade was a 13.46% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kenneth D. Denman purchased 14,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average price of $60.00 per share, for a total transaction of $840,000.00. Following the completion of the purchase, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. This represents a 240.01% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders acquired 411,032 shares of company stock worth $24,661,920.

About Representative FIELDS

Cleo Fields (Democratic Party) is a member of the U.S. House, representing Louisiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Fields (Democratic Party) is running for re-election to the U.S. House to represent Louisiana’s 6th Congressional District. He declared candidacy for the primary scheduled on November 3, 2026.

Cleo Fields graduated from McKinley High School in 1980. He earned a bachelor’s degree in mass communications from Southern University in 1984 and a J.D. from the Southern University Law Center in 1987. His career experience includes working as a state legislator and U.S. congressman. When Fields was elected to the Louisiana State Senate in 1986, he was the youngest person ever elected to the State Senate in Louisiana’s history. In 1995, Fields ran for governor of Louisiana, becoming the first African American since reconstruction to make the runoff.

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.